- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x U30: 3-[2-azanyl-6-[1-[[6-(2-oxidanylpropan-2-yl)pyridin-2-yl]methyl]-1,2,3-triazol-4-yl]pyrimidin-4-yl]-2-methyl-benzenecarbonitrile(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.3: 5 residues within 4Å:- Chain A: H.84, G.85, M.149
- Ligands: CLR.4, OLA.15
1 PLIP interactions:1 interactions with chain A- Water bridges: A:H.84
CLR.4: 8 residues within 4Å:- Chain A: F.71, A.81, A.82, G.85, F.88, I.89
- Ligands: CLR.3, OLC.25
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.71, A:F.88, A:I.89
- Hydrogen bonds: A:A.82
CLR.5: 10 residues within 4Å:- Chain A: L.349, L.352, P.353, I.357, F.360, C.367, S.368, A.370, L.374
- Ligands: OLA.8
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.349, A:L.352, A:P.353, A:I.357, A:F.360
- Hydrogen bonds: A:S.368
- Water bridges: A:S.368
CLR.6: 6 residues within 4Å:- Chain A: I.356, C.359, F.360, F.363, C.364
- Ligands: OLB.23
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.356, A:F.360, A:F.360, A:F.360, A:F.363
- 15 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.7: 5 residues within 4Å:- Chain A: T.74, T.77, F.79
- Ligands: OLC.25, OLC.27
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.74
- Hydrogen bonds: A:T.77
OLA.8: 4 residues within 4Å:- Chain A: P.371, W.373, L.377
- Ligands: CLR.5
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:P.371, A:W.373, A:L.377
OLA.9: 7 residues within 4Å:- Chain A: F.53, A.106, D.110, I.113, V.125, I.133, C.137
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:A.106, A:I.133
OLA.10: 5 residues within 4Å:- Chain A: V.34, C.37, W.38, W.41
- Ligands: OLB.24
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.34, A:W.41, A:W.41
- Hydrogen bonds: A:W.41
OLA.11: 4 residues within 4Å:- Chain A: L.199, L.203, Y.206, A.341
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Y.206
OLA.12: 6 residues within 4Å:- Chain A: G.14, V.17, Y.376, V.380, T.384
- Ligands: OLA.13
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.17, A:Y.376, A:V.380
OLA.13: 4 residues within 4Å:- Chain A: T.384, V.387, F.391
- Ligands: OLA.12
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:T.384, A:V.387, A:F.391, A:F.391
OLA.14: 2 residues within 4Å:- Chain A: G.345, L.346
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.346
OLA.15: 8 residues within 4Å:- Chain A: H.84, F.142, A.143, L.146, M.149
- Ligands: CLR.3, OLA.17, OLB.22
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.142, A:L.146
- Salt bridges: A:H.84
OLA.16: 1 residues within 4Å:- Ligands: OLC.27
No protein-ligand interaction detected (PLIP)OLA.17: 4 residues within 4Å:- Chain A: A.135, F.142
- Ligands: OLA.15, OLC.26
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.142, A:F.142
OLA.18: 1 residues within 4Å:- Chain A: W.373
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.373, A:W.373
OLA.19: 5 residues within 4Å:- Chain A: L.28, L.31, V.34, W.38, F.391
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.28, A:F.391
- Hydrogen bonds: A:L.31
OLA.20: 3 residues within 4Å:- Chain A: I.136
- Ligands: OLA.21, OLB.22
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.136
OLA.21: 8 residues within 4Å:- Chain A: T.128, R.129, G.132, I.136, V.139, L.140
- Ligands: OLA.20, OLB.22
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.136, A:I.136, A:V.139, A:L.140
- 3 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLB.22: 7 residues within 4Å:- Chain A: L.140, A.143, M.149, L.150
- Ligands: OLA.15, OLA.20, OLA.21
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.140, A:A.143, A:L.150
OLB.23: 5 residues within 4Å:- Chain A: F.192, F.363, P.365
- Ligands: CLR.6, OLC.28
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.363, A:F.363, A:F.363
- Hydrogen bonds: A:D.366
- Water bridges: A:D.366
OLB.24: 11 residues within 4Å:- Chain A: C.37, V.40, W.41, Q.47, Y.52, V.55, A.59, I.62, L.63
- Ligands: OLA.10, OLC.26
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.41, A:I.62, A:L.63
- Hydrogen bonds: A:Y.52, A:Y.52
- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
OLC.25: 11 residues within 4Å:- Chain A: V.66, L.67, P.70, F.71, T.74, F.79, C.80, Q.172
- Ligands: CLR.4, OLA.7, OLC.27
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:V.66, A:L.67, A:P.70, A:F.71, A:T.74, A:F.79, A:F.79
- Hydrogen bonds: A:C.80, A:C.80, A:Q.172, A:Q.172
OLC.26: 8 residues within 4Å:- Chain A: Y.52, V.55, A.59, G.127, I.134, W.138
- Ligands: OLA.17, OLB.24
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.55, A:I.134, A:W.138
OLC.27: 3 residues within 4Å:- Ligands: OLA.7, OLA.16, OLC.25
No protein-ligand interaction detected (PLIP)OLC.28: 5 residues within 4Å:- Chain A: Y.188, F.362, F.363, P.365
- Ligands: OLB.23
No protein-ligand interaction detected (PLIP)OLC.29: 8 residues within 4Å:- Chain A: P.11, I.12, S.15, S.16, I.19, T.20, S.76, T.77
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.12, A:I.19, A:T.20
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Claff, T. et al., Crystal structure of adenosine A 2A receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction. Commun Chem (2023)
- Release Date
- 2023-05-31
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x U30: 3-[2-azanyl-6-[1-[[6-(2-oxidanylpropan-2-yl)pyridin-2-yl]methyl]-1,2,3-triazol-4-yl]pyrimidin-4-yl]-2-methyl-benzenecarbonitrile(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 15 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 3 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Claff, T. et al., Crystal structure of adenosine A 2A receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction. Commun Chem (2023)
- Release Date
- 2023-05-31
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.